CEPHALON PHARMA ApS: Financial statements 2012
CVR: 28289375
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
CEPHALON PHARMA ApS (CVR 28289375) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,171,750 and a net result of DKK 146,379. Equity in the 2012 report amounted to DKK 978,445. The solvency ratio was 59.7%.
- Gross Profit
- DKK 1,171,750
- Profit/Loss
- DKK 146,379
- Equity
- DKK 978,445
- Total Assets
- DKK 1,639,358
Keep an eye on CEPHALON PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of June 4, 2012, Kim Vallentin Peetz is registered as direktion of CEPHALON PHARMA ApS.
As of June 4, 2012, Peter Mikael Burestedt is registered as direktion of CEPHALON PHARMA ApS.
As of June 4, 2012, Lone Juul Darket has stepped down as direktion of CEPHALON PHARMA ApS.
As of June 4, 2012, Tommie Rickard Jern has stepped down as direktion of CEPHALON PHARMA ApS.
About CEPHALON PHARMA ApS
CEPHALON PHARMA ApS was a Danish company of the type Anpartsselskab based in Kgs.Lyngby, founded in 2004 and dissolved in 2013. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2013). In 2012, the company reported a gross profit of DKK 1,171,750 and a net result of DKK 146,379. Equity in the 2012 report amounted to DKK 978,445.